Skip to main content
Log in

Drug-loaded polymer-coated silver nanoparticles for lung cancer theranostics

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Lung cancer is the leading cause of death in cancer across the globe. To minimize these deaths, the replacement of traditional chemotherapy with novel strategies is significant. We have developed a nanotheranostic approach using silver nanoparticles for imaging and treatment. Silver nanoparticles (AgNPs) are fabricated by chemical reduction method. The formulation of AgNPs was confirmed by different characterization techniques like stability test, UV–Visible spectroscopy, Confocal Raman Spectroscopy, and Energy-Dispersive X-ray analysis. Further, AgNPs are coated with poly lactic-co-glycolic acid (PLGA) and then loaded with paclitaxel (Pac). Then the drug-loaded PLGA-coated AgNPs were characterized for size and zeta potential measurement by zetasizer, surface morphology study by atomic force microscopy, Fourier transform infrared spectroscopy, and release kinetics study. The imaging and anticancer properties of these nanoformulations are investigated using lung cancer cell lines. The results proved that the particles are in the nanometer range with smooth surface morphology. Moreover, the drug-loaded NPs showed a sustained release of the drug for a longer period of time. Further the formulations showed imaging property with greater anticancer efficacy. Thus, the results suggest the effective use of these nanoformulation in both lung cancer imaging and treatment using a simple and efficient approach.

Graphical abstract

Schematic representation showing the mechanism of theranostic effect of PLGA coated Pac loaded silver nanoparticles. First silver nanoparticles were formulated then loaded with Pac and coated with PLGA. The formulated nanoparticles will enter into cells by the process of endocytosis and there it will release the drug and the silver. The drug will induce cytotoxicity whereas the silver nanoparticles will be used for imaging purpose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

No datasets were generated or analysed during the current study.

References

  1. Sharma P, et al. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. Chem Biol Interact. 2019;309:108720.

    Article  CAS  PubMed  Google Scholar 

  2. Jiang XQ, Mei XD, Feng D. Air pollution and chronic airway diseases: what should people know and do? J Thorac Dis. 2016;8(1):E31-40.

    PubMed  PubMed Central  Google Scholar 

  3. Siegel RL, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

    Article  PubMed  Google Scholar 

  4. Ahmad J, et al. Nanotechnology-based inhalation treatments for lung cancer: state of the art. Nanotechnol Sci Appl. 2015;8:55–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Sun SB, et al. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int J Clin Exp Med. 2015;8(10):19670–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Misra R, Acharya S. Smart nanotheranostic hydrogels for on-demand cancer management. Drug Discov Today. 2021;26(2):344–59.

    Article  CAS  PubMed  Google Scholar 

  7. Misra R, Das M, Biswas P, Nanda A. EGFR targeted Mn-doped ZnO fluorescent nanocrystals for cancer theranostic application. Mater Today Commun. 2021;26:102170.

    Article  CAS  Google Scholar 

  8. Bai Aswathanarayan J, Rai Vittal R, Muddegowda U. Anticancer activity of metal nanoparticles and their peptide conjugates against human colon adenorectal carcinoma cells. Artif Cells Nanomed Biotechnol. 2018;46(7):1444–51.

    Article  CAS  PubMed  Google Scholar 

  9. Farooqui MA, Chauhan PS, Krishnamoorthy P, Shaik J. Extraction of silver nanoparticles from the leaf extracts of Clerodendrum inerme. Digest J Nanomater Biostruct. 2010;5(1):43–9.

    Google Scholar 

  10. Jeyaraj M, et al. Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B Biointerfaces. 2013;106:86–92.

    Article  CAS  PubMed  Google Scholar 

  11. Zhang D, et al. Biosynthesized silver nanoparticles using Caulerpa taxifolia against A549 lung cancer cell line through cytotoxicity effect/morphological damage. Saudi J Biol Sci. 2020;27(12):3421–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Misra R, et al. Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for triple negative breast cancer therapy. Bioimpacts. 2021;11(3):199–207.

    Article  CAS  PubMed  Google Scholar 

  13. Muhammad N, et al. Silver nanoparticles functionalized paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells. Nanotechnology. 2021;32(8):085105.

    Article  CAS  PubMed  Google Scholar 

  14. Zou J, Zhu B, Li Y. Functionalization of silver nanoparticles loaded with paclitaxel-induced A549 cells apoptosis through ROS-mediated signaling pathways. Curr Top Med Chem. 2020;20(2):89–98.

    Article  CAS  PubMed  Google Scholar 

  15. Stevanović MM, et al. Poly (lactide-co-glycolide)/silver nanoparticles: synthesis, characterization, antimicrobial activity, cytotoxicity assessment and ROS-inducing potential. Polymer. 2012;53(14):2818–28.

    Article  Google Scholar 

  16. Khalil KA, Fouad H, Elsarnagawy T, Almajhdi FN. Preparation and characterization of electrospun PLGA/silver composite nanofibers for biomedical applications. Int J Electrochem Sci. 2013;8(3):3483–93.

    Article  Google Scholar 

  17. Rashid MU, Bhuiyan MKH, Quayum ME. Synthesis of silver nano particles (Ag-NPs) and their uses for quantitative analysis of vitamin C tablets. Dhaka Univ J Pharm Sci. 2013;12(1):29–33.

    Article  Google Scholar 

  18. Pathak K, Pattnaik S. Stability testing parameters and issues for nanotechnology-based drug products. In: Bajaj S, Singh S, editors. Methods for stability testing of pharmaceuticals. New York p: Springer; 2018. p. 293–305.

    Chapter  Google Scholar 

  19. Ashraf JM, et al. Green synthesis of silver nanoparticles and characterization of their inhibitory effects on AGEs formation using biophysical techniques. Sci Rep. 2016;6:20414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Estevez MB, Mitchell SG, Faccio R, Alborés S. Biogenic silver nanoparticles: understanding the antimicrobial mechanism using confocal raman microscopy. Mater Res Express. 2020;6(12):1250f5.

    Article  Google Scholar 

  21. Salatin S, et al. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Res Pharm Sci. 2017;12(1):1–14.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Misra R, et al. Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation. Int J Pharm. 2014;475(1–2):372–84.

    Article  CAS  PubMed  Google Scholar 

  23. Zhao J, et al. Enhancement of radiosensitization by silver nanoparticles functionalized with polyethylene glycol and aptamer As1411 for glioma irradiation therapy. Int J Nanomedicine. 2019;14:9483–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol. 2011;731:237–45.

    Article  PubMed  Google Scholar 

  25. Wlodkowic D, Skommer J, Darzynkiewicz Z. Flow cytometry-based apoptosis detection. Methods Mol Biol. 2009;559:19–32.

    Article  CAS  PubMed  Google Scholar 

  26. Herrera GM, Padilla AC, Hernandez-Rivera SP. Surface enhanced raman scattering (SERS) studies of gold and silver nanoparticles prepared by laser ablation. Nanomaterials (Basel). 2013;3(1):158–72.

    Article  CAS  PubMed  Google Scholar 

  27. Kora AJ, Arunachalam J. Green fabrication of silver nanoparticles by gum tragacanth (Astragalus gummifer): a dual functional reductant and stabilizer. J Nanomaterials. 2012. https://doi.org/10.1155/2012/869765.

    Article  Google Scholar 

  28. Liu F, et al. Ultrathin diamond-like carbon film coated silver nanoparticles-based substrates for surface-enhanced Raman spectroscopy. ACS Nano. 2010;4(5):2643–8.

    Article  CAS  PubMed  Google Scholar 

  29. Saleh TA, Al-Shalalfeh MM, Al-Saadi AA. Silver nanoparticles for detection of methimazole by surface-enhanced Raman spectroscopy. Mater Res Bull. 2017;91:173–8.

    Article  CAS  Google Scholar 

  30. Saleh TA, Al-Shalalfeh MM, Al-Saadi AA. Graphene dendrimer-stabilized silver nanoparticles for detection of methimazole using Surface-enhanced Raman scattering with computational assignment. Sci Rep. 2016;6:32185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Guzmán MG, Dille J, Godet S. Synthesis of silver nanoparticles by chemical reduction method and their antibacterial activity. Int J Chem Biomol Eng. 2009;2(3):104–11.

    Google Scholar 

  32. Yaseen B, et al. Detailed kinetic and mechanistic study for the preparation of silver nanoparticles by a chemical reduction method in the presence of a neuroleptic agent (gabapentin) at an alkaline pH and its characterization. ACS Omega. 2022;7(7):5739–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hakkimane SS, et al. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain. Int J Nanomedicine. 2018;13:4303–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ganachari SV, Bhat R, Deshpande R, Venkataraman A. Extracellular biosynthesis of silver nanoparticles using fungi Penicillium diversum and their antimicrobial activity studies. BioNanoScience. 2012;2(4):316–21.

    Article  Google Scholar 

  35. Bankar A, Joshi B, Ravi Kumar A, Zinjarde S. Banana peel extract mediated synthesis of gold nanoparticles. Colloids Surf B. 2010;80(1):45–50.

    Article  CAS  Google Scholar 

  36. Ramesh Kumar K, Nattuthurai GP, Mariappan T. Biosynthesis of silver nanoparticles from Morinda tinctoria leaf extract and their larvicidal activity against Aedes aegypti linnaeus 1762. J Nanomed Nanotechnol. 2014. https://doi.org/10.4172/2157-7439.1000242.

    Article  Google Scholar 

  37. Cao Y, et al. Ultrasmall graphene oxide supported gold nanoparticles as adjuvants improve humoral and cellular immunity in mice. Adv Func Mater. 2014;24(44):6963–71.

    Article  CAS  Google Scholar 

  38. Sadat Shandiz SA, et al. Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells. Artif Cells Nanomed Biotechnol. 2017;45(6):1–10.

    Article  PubMed  Google Scholar 

  39. Loiseau A, et al. Silver-based plasmonic nanoparticles for and their use in biosensing. Biosensors (Basel). 2019;9(2):78.

    Article  CAS  PubMed  Google Scholar 

  40. Sahoo AK, et al. Silver nanocluster embedded composite nanoparticles for targeted prodrug delivery in cancer theranostics. ACS Biomater Sci Eng. 2016;2(8):1395–402.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

RM acknowledges to the DST-SERB-TARE (TAR/2021/000137) and UGC-DAE-CRS (CRS/2022-23/954) for funding.

Funding

The authors have not disclosed any funding.

Author information

Authors and Affiliations

Authors

Contributions

RM: designed the whole work and helped in the manuscript writing. SN: did the nanoparticle synthesis and characterization and wrote the manuscript by taking help from RM. SS: has done the cell culture experiments. SH help in silver nanoparticle synthesis.

Corresponding author

Correspondence to Ranjita Misra.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Misra, R., Hazra, S., Saleem, S. et al. Drug-loaded polymer-coated silver nanoparticles for lung cancer theranostics. Med Oncol 41, 132 (2024). https://doi.org/10.1007/s12032-024-02372-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-024-02372-y

Keywords

Navigation